SEC 13F Intelligence

Euclidean Technologies Management, LLC / ANIK

Euclidean Technologies Management, LLC’s Anika Therapeutics Inc Position

Does Euclidean Technologies Management, LLC own Anika Therapeutics Inc (ANIK)? Not currently — the last reported position was 44.9K shares worth $2M in Q1 2021; the fund’s latest 13F (Q1 2023) no longer reports it.

Position Value
$2M
Q1 2021
Shares
44.9K
% of Portfolio
+1.59%
Quarters Held
5
position exited

Position History ANIK

Reported value by quarter
Q1 ’20: $1MQ1 ’20Q2 ’20: $2MQ2 ’20Q3 ’20: $2MQ3 ’20Q4 ’20: $2MQ4 ’20Q1 ’21: $2MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202144.9K$2M+1.59%
Q4 202044.9K$2M+2.14%
Q3 202042.4K$2M+1.89%
Q2 202042.4K$2M+2.24%
Q1 202042.4K$1M+2.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Euclidean Technologies Management, LLC’s full portfolio or all institutional holders of ANIK.